- Home
- 免费应用程序分析
- TBSS score
- TBSS score Vs. Ethos PHR
TBSS score 对比 Ethos PHR 的使用情况和统计数据
This application calculates TBSS (Traumatic Bleeding Severity Score).
TBSS is a scoring system that quickly predicts the need for massive transfusion in severely injured patients.
the TBSS is calculated using only five clinical variables: the patient's age, systolic blood pressure, results from the focused assessment with sonography for trauma scan (FAST), the presence or severity of a pelvic fracture, and serum lactate levels . In Japan, it has shown high accuracy through both internal and external validations. Furthermore, based on sensitivity and specificity, TBSS scores are used to categorize risk into categories (Low risk, Gray zone [indeterminate risk], High risk), designed to allow for immediate determination of the need for massive transfusion.
【Information Source】
The medical information in this app was presented at the 23rd European Congress of Trauma and Surgery and was created by the lead speaker.
https://programme.conventus.de/en/ectes-2024/program/program-points/10cbe0b5-fb02-4043-b48a-c037a9eba207
【Usage Disclaimer】
This application was created to assist in TBSS calculations. However, it is not intended that judgments be made solely based on this application, and there is no guarantee of quality, performance, accuracy, or freshness of information. Therefore, when using clinically, please consider these risks and make a comprehensive judgment on whether the use of this application and its results are appropriate, taking responsibility as a user.
The creators, providers, and supervising physicians of this application are not responsible for any direct or indirect damages resulting from the use of this application. For details, please refer to the iTunes Store Terms of Service and the Licensed Application End User License Agreement.
This application is not a medical device.
- Apple 应用商店
- 免费
- 医疗
商店排名
- -
TBSS score与Ethos PHR排名比较
对比 TBSS score 与 Ethos PHR 在过去 28 天内的排名趋势
排名
没有可用的数据
TBSS score VS.
Ethos PHR
一月 1, 2025